Abdelalim Essam M, Emara Mohamed M
Essam M Abdelalim, Mohamed M Emara, Qatar Biomedical Research Institute, Qatar Foundation, Education City, PO Box 5825, Doha, Qatar.
World J Stem Cells. 2015 Jan 26;7(1):174-81. doi: 10.4252/wjsc.v7.i1.174.
Pluripotent stem cells (PSCs) are able to differentiate into several cell types, including pancreatic β cells. Differentiation of pancreatic β cells depends on certain transcription factors, which function in a coordinated way during pancreas development. The existing protocols for in vitro differentiation produce pancreatic β cells, which are not highly responsive to glucose stimulation except after their transplantation into immune-compromised mice and allowing several weeks for further differentiation to ensure the maturation of these cells in vivo. Thus, although the substantial improvement that has been made for the differentiation of induced PSCs and embryonic stem cells toward pancreatic β cells, several challenges still hindering their full generation. Here, we summarize recent advances in the differentiation of PSCs into pancreatic β cells and discuss the challenges facing their differentiation as well as the different applications of these potential PSC-derived β cells.
多能干细胞(PSCs)能够分化为多种细胞类型,包括胰腺β细胞。胰腺β细胞的分化取决于某些转录因子,这些转录因子在胰腺发育过程中以协调的方式发挥作用。现有的体外分化方案可产生胰腺β细胞,但这些细胞对葡萄糖刺激的反应性不高,除非将其移植到免疫缺陷小鼠体内,并经过数周的进一步分化以确保这些细胞在体内成熟。因此,尽管在诱导多能干细胞和胚胎干细胞向胰腺β细胞的分化方面已经取得了显著进展,但仍有几个挑战阻碍着它们的完全生成。在这里,我们总结了多能干细胞向胰腺β细胞分化的最新进展,并讨论了其分化面临的挑战以及这些潜在的多能干细胞衍生的β细胞的不同应用。